Anaptysbio Inc (ANAB)

R&D to Revenue

9.84%

Quarterly · Period ending:

ANAB logo

ANAB R&D to Revenue

Latest reported9.84%
ANAB Quarterly R&D/Revenue (103.43% → 9.84%)
High-resolution chart · PNG

ANAB r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Anaptysbio Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
9.837%
132.4973%
23.6113%
41.1517%
169.8962%
148.2842%
98.7846%
140.627%
382.8001%
515.9772%
453.7923%
930.6209%
951.5318%
2,544.1776%
343.3314%
1,706.4192%
1,714.1447%
2,321.2371%
2,648.4695%
106.3715%
84.3041%
215.0351%
35.945%
0%
0%
139.7867%
714.2%
0%
547%
0%
0%
357.66%
0%
0%
256.8667%
0%
111.5%
0%
218.4459%
201.6801%
91.1966%
98.3559%
88.1105%
161.8114%
68.1073%
74.7864%
70.3104%
34.6279%
48.4993%
103.425%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.